Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacific Edge Limited

0.0623
0.0000
Volume:- -
Turnover:- -
Market Cap:50.58M
PE:-2.76
High:0.0623
Open:0.0623
Low:0.0623
Close:0.0623
Loading ...

Company Profile

Company Name:
Pacific Edge Limited
Exchange:
PINK
Establishment Date:
2001
Employees:
114
Office Location:
Centre for Innovation,87 St David Street,PO Box 56,Dunedin,New Zealand
Website:
- -
Zip Code:
9016
Fax:
64 3 974 9393
Introduction:
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. The company operates in two segments, Commercial and Research. It offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. The company is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, it is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. The company was incorporated in 2001 and is headquartered in Dunedin, New Zealand.